Amblyopia

DENVER — The rate of pediatric patients with amblyopia lost to follow-up is higher among those with public insurance, according to a presenter.

DENVER — Playing stereoscopic 3D video games could improve stereoacuity and potentially benefit patients with amblyopia, according to a study presented at the Association for Research in Vision and Ophthalmology meeting.

In this Healio Video Perspective, Tamara Wygnanski-Jaffe, MD, discusses results from a pivotal trial with the CureSight digital amblyopia treatment vs. patching.

CureSight, a digital treatment device, was noninferior to eye patching for pediatric amblyopia in a pivotal clinical study, NovaSight announced in a press release.

A hand-held vision screening device reliably detected amblyopia in a general pediatric population, according to research published in the Journal of AAPOS.

BOSTON – RevitalVision is a prescribed vision training software that stimulates the brain’s visual cortex to improve vision in patients with amblyopia from the age of 9 years through adulthood, RevitalVision founder and CEO, Yair Yahav, said here at the American Academy of Optometry annual meeting.

The FDA has granted de novo premarket approval for Luminopia One, a digital therapy for children aged 4 to 7 years with amblyopia, according to a press release from Luminopia.

Pervasive digital device use is associated with symptoms such as eye strain, headaches, dry eye disease, and neck and shoulder pain. Together, these symptoms are ubiquitous and known as digital vision syndrome, or DVS.

A dichoptic digital therapeutic from Luminopia plus full-time glasses improved vision in children with amblyopia compared with full-time glasses alone, according to a pivotal phase 3 randomized controlled trial in Ophthalmology.

Luminopia One, an investigational digital therapy that allows patients with amblyopia to watch visually modified TV shows and movies to improve vision, has shown positive results, according to a press release from Luminopia.